These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19834489)

  • 21. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired neurogenesis, learning and memory and low seizure threshold associated with loss of neural precursor cell survivin.
    Coremans V; Ahmed T; Balschun D; D'Hooge R; DeVriese A; Cremer J; Antonucci F; Moons M; Baekelandt V; Reumers V; Cremer H; Eisch A; Lagace D; Janssens T; Bozzi Y; Caleo M; Conway EM
    BMC Neurosci; 2010 Jan; 11():2. PubMed ID: 20051123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential role for survivin in early brain development.
    Jiang Y; de Bruin A; Caldas H; Fangusaro J; Hayes J; Conway EM; Robinson ML; Altura RA
    J Neurosci; 2005 Jul; 25(30):6962-70. PubMed ID: 16049172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
    Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
    Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H
    Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired muscle regeneration and myoblast differentiation in mice with a muscle-specific KO of IGF-IR.
    Heron-Milhavet L; Mamaeva D; LeRoith D; Lamb NJ; Fernandez A
    J Cell Physiol; 2010 Oct; 225(1):1-6. PubMed ID: 20458740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
    Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
    [No Abstract]   [Full Text] [Related]  

  • 31. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways.
    Fukuda S; Mantel CR; Pelus LM
    Blood; 2004 Jan; 103(1):120-7. PubMed ID: 12969960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear degradation of Wilms tumor 1-associating protein and survivin splice variant switching underlie IGF-1-mediated survival.
    Small TW; Pickering JG
    J Biol Chem; 2009 Sep; 284(37):24684-95. PubMed ID: 19605357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.
    Steller MA; Zou Z; Schiller JT; Baserga R
    Cancer Res; 1996 Nov; 56(21):5087-91. PubMed ID: 8895768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
    Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
    Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation.
    Novosyadlyy R; Vijayakumar A; Lann D; Fierz Y; Kurshan N; LeRoith D
    Oncogene; 2009 Oct; 28(39):3477-86. PubMed ID: 19617901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines.
    Li F; Ling X; Huang H; Brattain L; Apontes P; Wu J; Binderup L; Brattain MG
    Oncogene; 2005 Feb; 24(8):1385-95. PubMed ID: 15608672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
    Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
    Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
    Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.